Osteochondroma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

NGS Strategy Effectiveness in Molecular Diagnosis
Conditions: Multiple Osteochondroma; Osteogenesis Imperfecta Intervention: Diagnostic Test: NGS molecular screening Sponsors: Istituto Ortopedico Rizzoli; Catholic University of the Sacred Heart; Regione Emilia-Romagna Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2018 Category: Research Source Type: clinical trials

Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
MONTREAL, April 20, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage company innovating new treatments for people with ultra-rare bone disorders and other diseases, today announced the start of the MO-Ped... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 20, 2018 Category: Pharmaceuticals Source Type: clinical trials